Zimmer Biomet’s Strategic Transformation Pivots to Active Portfolio Management
The company grew +2.9% in 3Q20 as it begins a new phase of its strategic transformation that includes focus on high growth business lines. Nov 09, 2020
ATEC Closes 3Q20 with Best Month in Company History
The company grew +41% in 3Q20, driven by a record-breaking September. ATEC sees itself as well-positioned to take share from both large and small players. Nov 09, 2020
Anika Growth Driven by Arthrosurface and Parcus Acquisitions
While the company's orthobiologics business remains impacted by COVID, gains from joint preservation and restoration products offset the losses. Nov 06, 2020
Conformis Hurt by Slower Recovery of Total Joint Replacement Surgeries
The company declined -6.8% in 3Q20, as it remains impacted by the slower recovery of primary arthroplasty surgeries compared to revision and trauma. Nov 05, 2020
SI-BONE Surges on Reimbursement Wins and Backlogged Procedures
The company grew nearly 26% for 3Q20, driven by continuing favorable coverage policies in the U.S. and backlogged procedures in July. Nov 05, 2020
NuVasive Sees Flattening Recovery Curve for Spinal Surgeries
The company grew +1.5% in 3Q20. While spine surgery volume is approaching pre-COVID levels, the company does not expect overall market growth in 2020. Nov 03, 2020
Stryker Growth Driven by Mako and ASC Gains
The progressive return of elective procedures and demand for Mako drove the company’s V-shaped recovery from the second quarter pandemic low point. Nov 02, 2020
Smith+Nephew Dragged Down by Weak Sales in Knees and Emerging Markets
While the company improved sequentially, weakness in emerging markets, and significant knee replacement losses hobbled its recovery. Nov 02, 2020
Integra Returns to Growth on Backlogged Procedures
The company grew its soon to be divested orthopedic franchise +5.1% in 3Q20 as momentum from backlogged procedures carried into the third quarter. Oct 30, 2020
ConMed’s Recovery Blunted by Slow Capital Sales
The company's revenue declined -7.4% in 3Q20 as capital sales remain slow, and the lack of team sports activity depresses sports medicine procedure volumes. Oct 30, 2020
